Brief Report - (2025) Volume 16, Issue 3
Received: 02-Jun-2025, Manuscript No. jfr-26-184099;
Editor assigned: 04-Jun-2025, Pre QC No. P-184099;
Reviewed: 18-Jun-2025, QC No. Q-184099;
Revised: 23-Jun-2025, Manuscript No. R-184099;
Published:
30-Jun-2025
, DOI: 10.37421/2157-7145.2025.16.660
Citation: Romano, Isabella. ”Advanced Biomarkers For Accurate
Postmortem Interval Estimation.” J Forensic Res 16 (2025):660.
Copyright: © 2025 Romano I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
The estimation of the postmortem interval (PMI) is a critical aspect of forensic investigations, guiding timelines and aiding in the reconstruction of events surrounding a death. Traditional methods, while foundational, often have limitations in accuracy and the duration of their applicability. In response, contemporary research has increasingly focused on the development and refinement of molecular and biochemical markers that can offer more precise and extended PMI estimations. Biochemical markers represent a significant advancement in this field, moving beyond macroscopic observations to quantifiable molecular changes occurring after death. This avenue of research explores the utility of specific proteins and enzymes found in various biological fluids and tissues to determine the time elapsed since death. Advances in molecular biology and analytical techniques are enabling more precise quantification of these markers, allowing for the correlation of their degradation patterns with time, aiming to establish reliable, standardized protocols for forensic use [1].
The analysis of chemical changes within bodily fluids, such as vitreous humor, has also emerged as a valuable tool for PMI determination. Specifically, temporal changes in ion concentrations (potassium, sodium, and chloride) and metabolic products (glucose and lactate) have been investigated in relation to the time since death. These findings underscore the potential of these analytes as reliable indicators, particularly within the early postmortem period, with researchers also discussing the influence of environmental factors on their behavior [2].
Beyond fluid analysis, molecular degradation patterns within solid tissues are being leveraged for PMI estimation. The utility of RNA degradation patterns in skeletal muscle, for instance, is being explored by quantifying specific mRNA transcripts and their decay rates to establish a timeline. This approach demonstrates that RNA analysis can serve as a complementary method, offering a wider postmortem window of estimation and resilience to certain environmental conditions [3].
Further exploration into fluid-based biomarkers includes the analysis of protein changes in cerebrospinal fluid (CSF). This research investigates the temporal stability and degradation of various proteins, such as albumin and total protein, in CSF samples. The objective is to establish correlations between protein concentrations and postmortem times, thereby identifying potential markers that remain accessible even in cases of advanced decomposition [4].
Advanced proteomic techniques offer a sophisticated approach to PMI estimation by identifying and quantifying proteins that undergo predictable changes after death. Utilizing methods like mass spectrometry, researchers are exploring proteomic signatures that can provide more accurate and extended PMI estimation ranges, especially in challenging scenarios involving decomposition [5].
Complementary to chemical and molecular analyses, microbial community dynamics are being investigated for their potential in PMI estimation. The succession of microbial communities within decomposing tissues and their correlation with time since death are examined, highlighting microbial profiling as a potentially independent method, particularly useful when insect activity is limited [6].
The reliability of enzymatic activity in postmortem tissues also continues to be assessed for its utility in PMI estimation. Research focusing on the kinetics of specific enzymes, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT), in tissues like the liver and blood aims to establish clear relationships between enzyme levels and time postmortem, while accounting for influencing factors like temperature and tissue type [7].
Emerging biomarkers include circulating cell-free DNA (cfDNA) found in blood. The analysis of cfDNA release and degradation patterns after death is being investigated to determine if fragment length and concentration can serve as reliable indicators for PMI, particularly within the initial postmortem period [8].
Finally, the investigation into adipose tissue lipids offers another distinct avenue for PMI estimation. This research focuses on the fatty acid profile and lipid oxidation markers in subcutaneous fat over time, aiming to ascertain the feasibility of using these biochemical changes as a temporal indicator, especially when other tissues are compromised [9].
The ongoing quest for precise postmortem interval (PMI) estimation has driven significant research into a variety of biological markers. Biochemical markers, in general, are being investigated as a promising avenue to refine PMI estimations, moving beyond the limitations of traditional methods. This research encompasses the exploration of specific proteins and enzymes found in diverse biological fluids and tissues, aiming to accurately determine the time elapsed since death. The rapid advancements in molecular biology and analytical techniques are crucial, enabling more precise quantification of these markers and establishing correlations between their degradation patterns and time. The ultimate goal is to develop reliable, standardized protocols for their integration into forensic investigations [1].
Within this broad scope, vitreous humor chemistry has garnered attention as a tool for PMI estimation. Studies have meticulously examined the temporal changes in potassium, sodium, and chloride ion concentrations, alongside glucose and lactate levels, in relation to time since death. The findings consistently highlight the potential of these ions and metabolites as reliable markers, particularly effective in the early postmortem stages. Furthermore, the influence of environmental factors on the kinetics of these analytes is a key consideration in their application [2].
Moving from fluids to solid tissues, the degradation patterns of RNA in skeletal muscle are being investigated as a molecular clock for PMI estimation. This research quantifies specific mRNA transcripts and their decay rates to establish a timeline. The demonstration that RNA analysis can provide a valuable complementary method to existing techniques is significant, offering a broader postmortem estimation window and demonstrating resilience to certain environmental conditions [3].
Cerebrospinal fluid (CSF) is another biological matrix being explored for its protein profiles in PMI determination. This line of inquiry investigates the temporal stability and degradation of various proteins, including albumin and total protein, within CSF samples collected postmortem. The research strives to establish clear correlations between protein concentrations and postmortem times, presenting a potential marker accessible even in advanced decomposition scenarios [4].
Advanced proteomic techniques are also being harnessed for PMI estimation, employing methods like mass spectrometry to identify and quantify proteins exhibiting predictable postmortem changes. The exploration of these proteomic signatures holds the potential to deliver more accurate and extended PMI estimation ranges, proving particularly valuable in challenging decomposition environments [5].
Complementary to the molecular and chemical approaches, microbial community analysis in decomposing tissues is emerging as a potential tool for PMI estimation. This research examines the succession of microbial communities and their correlation with time since death. The findings underscore the potential of microbial profiling as an independent method for PMI determination, especially in scenarios where insect activity is limited or absent [6].
The reliability of enzymatic activity within postmortem tissues for PMI estimation is also under rigorous assessment. This research focuses on the kinetics of specific enzymes, such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT), in tissues like the liver and blood. The objective is to establish precise relationships between enzyme levels and time postmortem, while carefully considering variables such as temperature and tissue type that can influence these kinetics [7].
Circulating cell-free DNA (cfDNA) in blood represents a novel biomarker for PMI estimation. This area of research investigates the release and degradation patterns of cfDNA in the bloodstream following death. The central question is whether cfDNA fragment length and concentration can serve as reliable biomarkers for PMI, particularly during the early postmortem interval [8].
Furthermore, the postmortem changes in adipose tissue lipids are being investigated for their utility in PMI estimation. This study concentrates on the fatty acid profile and lipid oxidation markers present in subcutaneous fat over time. The research aims to determine the feasibility of employing these biochemical alterations in adipose tissue as a temporal indicator, especially in cases where other tissues may be compromised [9].
Finally, the quantification of specific microRNAs (miRNAs) in biological fluids is being explored for PMI estimation. This research examines the differential expression of miRNAs in body fluids like blood and urine at various postmortem intervals. The findings indicate that miRNAs are promising, stable biomarkers that can offer a wide window for PMI determination, even in complex forensic situations [10].
Current forensic science is rapidly advancing the estimation of the postmortem interval (PMI) by exploring novel biochemical and molecular markers. Research is focusing on proteins, enzymes, and their degradation patterns in various biological fluids (vitreous humor, CSF, blood, urine) and tissues (skeletal muscle, adipose tissue) to provide more accurate and extended timelines. Techniques such as proteomic analysis and RNA degradation studies are being employed. Additionally, microbial succession and circulating cell-free DNA (cfDNA) are being investigated as potential indicators. The goal is to develop standardized protocols for these advanced methods to complement or surpass traditional techniques in forensic investigations.
Journal of Forensic Research received 2328 citations as per Google Scholar report
